早期急性微血管肾移植排斥反应:无抗HLA抗体但存在针对多种肾小球内皮细胞抗原的预存IgG抗体
该研究纳入38例无抗HLA供者特异性抗体但发生早期急性微血管排斥(AMVR)的肾移植受者,通过交叉匹配实验、转录组和蛋白质组分析,发现AMVR患者血清中存在针对肾小球微血管内皮细胞组成性抗原的IgG反应,且靶点个体间差异大,提示非HLA抗体参与早期AMVR。
要点
- 无抗HLA抗体的早期AMVR患者中,26%可检出AT1R抗体(阈值10 IU/ml)。
- AMVR活检常见微血管炎症、血管炎(60.5%)、间质出血(31.6%)或血栓性微血管病(15.8%)。
- 基于细胞的体外实验有助于移植前风险评估。
核心结论
- 预存的针对肾小球内皮细胞非HLA抗原的IgG抗体与早期急性微血管排斥相关。
研究设计与样本
- 全国性研究,纳入38例无抗HLA供者特异性抗体但移植后3个月内出现急性移植物功能障碍和微血管损伤证据的肾移植受者。
主要发现
- 活检显示强烈微血管炎症,血管炎占60.5%,间质出血占31.6%,血栓性微血管病占15.8%。
- AMVR患者中AT1R、内皮素1型A受体和天然多反应性抗体较稳定对照组未显著升高,但26%的AMVR样本AT1R抗体阳性(阈值10 IU/ml)。
- 交叉匹配实验发现AMVR患者存在针对肾小球微血管细胞组成性抗原的共同IgG反应。
- 转录组和蛋白质组分析鉴定出新的非HLA抗体靶点,个体间冗余少。
临床怎么用
- 移植前可考虑采用基于细胞的体外实验评估非HLA抗体风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although anti-HLA antibodies (Abs) cause most antibody-mediated rejections of renal allografts, non-anti-HLA Abs have also been postulated to contribute. A better understanding of such Abs in rejection is needed. METHODS: We conducted a nationwide study to identify kidney transplant recipients without anti-HLA donor-specific Abs who experienced acute graft dysfunction within 3 months after transplantation and showed evidence of microvascular injury, called acute microvascular rejection (AMVR). We developed a crossmatch assay to assess serum reactivity to human microvascular endothelial cells, and used a combination of transcriptomic and proteomic approaches to identify non-HLA Abs. RESULTS: We identified a highly selected cohort of 38 patients with early acute AMVR. Biopsy specimens revealed intense microvascular inflammation and the presence of vasculitis (in 60.5%), interstitial hemorrhages (31.6%), or thrombotic microangiopathy (15.8%). Serum samples collected at the time of transplant showed that previously proposed anti-endothelial cell Abs-angiotensin type 1 receptor (AT1R), endothelin-1 type A and natural polyreactive Abs-did not increase significantly among patients with AMVR compared with a control group of stable kidney transplant recipients. However, 26% of the tested AMVR samples were positive for AT1R Abs when a threshold of 10 IU/ml was used. The crossmatch assay identified a common IgG response that was specifically directed against constitutively expressed antigens of microvascular glomerular cells in patients with AMVR. Transcriptomic and proteomic analyses identified new targets of non-HLA Abs, with little redundancy among individuals. CONCLUSIONS: Our findings indicate that preformed IgG Abs targeting non-HLA antigens expressed on glomerular endothelial cells are associated with early AMVR, and that in vitro cell-based assays are needed to improve risk assessments before transplant.
引用
- Delville M, Lamarthée B, Pagie S, et al. Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens. J Am Soc Nephrol. 2019. PMID: 30850439. doi:10.1681/ASN.2018080868
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。